|
1
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4422006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seligman ME and Csikszentmihalyi M:
Positive psychology: an introduction. Springer. Netherlands,
Dordrecht: 279–298. 2014.
|
|
3
|
Murphy DL, Cohen RM, Siever LJ, Roy B,
Karoum F, Wyatt RJ, Garrick NA and Linnoila M: Clinical and
laboratory studies with selective monoamine-oxidase-inhibiting
drugs. Implications for hypothesized neurotransmitter changes
associated with depression and antidepressant drug effects. Mod
Probl Pharmacopsychiatry. 19:287–303. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ader R and Cohen N: High time for
psychoimmunology. Nature. 315:103–104. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maes M: Evidence for an immune response in
major depression: A review and hypothesis. Prog
Neuropsychopharmacol Biol Psychiatry. 19:11–38. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maes M, Berk M, Goehler L, Song C,
Anderson G, Gałecki P and Leonard B: Depression and sickness
behavior are Janus-faced responses to shared inflammatory pathways.
BMC Med. 10:662012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Skaper SD, Facci L and Giusti P:
Neuroinflammation, microglia and mast cells in the pathophysiology
of neurocognitive disorders: a review. CNS Neurol Disord Drug
Targets. 13:1654–1666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maes M, Van de Vyvere J, Vandoolaeghe E,
Bril T, Demedts P, Wauters A and Neels H: Alterations in iron
metabolism and the erythron in major depression: Further evidence
for a chronic inflammatory process. J Affect Disord. 40:23–33.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith RS: The macrophage theory of
depression. Med Hypotheses. 35:298–306. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patel A: Review: The role of inflammation
in depression. Psychiatr Danub. 25:(Suppl 2). S216–S223.
2013.PubMed/NCBI
|
|
11
|
Dantzer R: Cytokine, sickness behavior,
and depression. Immunol Allergy Clin North Am. 29:247–264. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hart BL: Biological basis of the behavior
of sick animals. Neurosci Biobehav Rev. 12:123–137. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kent S, Bluthe RM, Dantzer R, Hardwick AJ,
Kelley KW, Rothwell NJ and Vannice JL: Different receptor
mechanisms mediate the pyrogenic and behavioral effects of
interleukin 1. Proc Natl Acad Sci USA. 89:9117–9120. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raison CL, Capuron L and Miller AH:
Cytokines sing the blues: Inflammation and the pathogenesis of
depression. Trends Immunol. 27:24–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Irwin M: Immune correlates of depression.
Adv Exp Med Biol. 461:1–24. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cruess DG, Douglas SD, Petitto JM, Have
TT, Gettes D, Dubé B, Cary M and Evans DL: Association of
resolution of major depression with increased natural killer cell
activity among HIV-seropositive women. Am J Psychiatry.
162:2125–2130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Evans DL, Ten Have TR, Douglas SD, Gettes
DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE,
Wang YL, et al: Association of depression with viral load, CD8 T
lymphocytes, and natural killer cells in women with HIV infection.
Am J Psychiatry. 159:1752–1759. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pike JL and Irwin MR: Dissociation of
inflammatory markers and natural killer cell activity in major
depressive disorder. Brain Behav Immun. 20:169–174. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Papanicolaou DA, Wilder RL, Manolagas SC
and Chrousos GP: The pathophysiologic roles of interleukin-6 in
human disease. Ann Intern Med. 128:127–137. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Ho RC and Mak A: Interleukin
(IL)-6, tumour necrosis factor alpha (TNF-α) and soluble
interleukin-2 receptors (sIL-2R) are elevated in patients with
major depressive disorder: A meta-analysis and meta-regression. J
Affect Disord. 139:230–239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brebner K, Hayley S, Zacharko R, Merali Z
and Anisman H: Synergistic effects of interleukin-1β,
interleukin-6, and tumor necrosis factor-α: Central monoamine,
corticosterone, and behavioral variations. Neuropsychopharmacology.
22:566–580. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carvalho LA, Urbanova L, Hamer M, Hackett
RA, Lazzarino AI and Steptoe A: Blunted glucocorticoid and
mineralocorticoid sensitivity to stress in people with diabetes.
Psychoneuroendocrinology. 51:209–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McInnis CM, Thoma MV, Gianferante D,
Hanlin L, Chen X, Breines JG, Hong S and Rohleder N: Measures of
adiposity predict interleukin-6 responses to repeated psychosocial
stress. Brain Behav Immun. 42:33–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ershler WB and Keller ET: Age-associated
increased interleukin-6 gene expression, late-life diseases, and
frailty. Annu Rev Med. 51:245–270. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Windham BG, Simpson BN, Lirette S, Bridges
J, Bielak L, Peyser PA, Kullo I, Turner S, Griswold ME and Mosley
TH: Associations between inflammation and cognitive function in
African Americans and European Americans. J Am Geriatr Soc.
62:2303–2310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huber SA, Sakkinen P, Conze D, Hardin N
and Tracy R: Interleukin-6 exacerbates early atherosclerosis in
mice. Arterioscler Thromb Vasc Biol. 19:2364–2367. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T, Chen Y, Liu H, Zhou Z, Zhai Y and
Yang J: Chronic unpredictable stress accelerates atherosclerosis
through promoting inflammation in apolipoprotein E knockout mice.
Thromb Res. 126:386–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song C, Dinan T and Leonard BE: Changes in
immunoglobulin, complement and acute phase protein levels in the
depressed patients and normal controls. J Affect Disord.
30:283–288. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yudkin JS, Yajnik CS, Mohamed-Ali V and
Bulmer K: High levels of circulating proinflammatory cytokines and
leptin in urban, but not rural, Indians. A potential explanation
for increased risk of diabetes and coronary heart disease. Diabetes
Care. 22:363–364. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baker DG, Ekhator NN, Kasckow JW, Hill KK,
Zoumakis E, Dashevsky BA, Chrousos GP and Geracioti TD Jr: Plasma
and cerebrospinal fluid interleukin-6 concentrations in
posttraumatic stress disorder. Neuroimmunomodulation. 9:209–217.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nguyen KT, Deak T, Owens SM, Kohno T,
Fleshner M, Watkins LR and Maier SF: Exposure to acute stress
induces brain interleukin-1β protein in the rat. J Neurosci.
18:2239–2246. 1998.PubMed/NCBI
|
|
33
|
Levine J, Barak Y, Chengappa KN, Rapoport
A, Rebey M and Barak V: Cerebrospinal cytokine levels in patients
with acute depression. Neuropsychobiology. 40:171–176. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prolla TA: DNA microarray analysis of the
aging brain. Chem Senses. 27:299–306. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi SH and Suh KY: Interleukin-1
beta,-2,-6 production, serum concentration and
hypothalamic-pituitary-adrenal axis in patients with major
depression. J Korean Neuropsychiatr Assoc. 37:537–547. 1998.
|
|
36
|
Thomas AJ, Davis S, Morris C, Jackson E,
Harrison R and O'Brien JT: Increase in interleukin-1β in late-life
depression. Am J Psychiatry. 162:175–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Corwin EJ, Johnston N and Pugh L: Symptoms
of postpartum depression associated with elevated levels of
interleukin-1 beta during the first month postpartum. Biol Res
Nurs. 10:128–133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ovaskainen Y, Koponen H, Jokelainen J,
Keinänen-Kiukaanniemi S, Kumpusalo E and Vanhala M: Depressive
symptomatology is associated with decreased interleukin-1 beta and
increased interleukin-1 receptor antagonist levels in males.
Psychiatry Res. 167:73–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cousins RJ and Leinart AS: Tissue-specific
regulation of zinc metabolism and metallothionein genes by
interleukin 1. FASEB J. 2:2884–2890. 1988.PubMed/NCBI
|
|
40
|
Nolan Y, Maher FO, Martin DS, Clarke RM,
Brady MT, Bolton AE, Mills KH and Lynch MA: Role of interleukin-4
in regulation of age-related inflammatory changes in the
hippocampus. J Biol Chem. 280:9354–9362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
O'Donovan A, Rush G, Hoatam G, Hughes BM,
McCrohan A, Kelleher C, O'Farrelly C and Malone KM: Suicidal
ideation is associated with elevated inflammation in patients with
major depressive disorder. Depress Anxiety. 30:307–314. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mesquita AR, Correia-Neves M, Roque S,
Castro AG, Vieira P, Pedrosa J, Palha JA and Sousa N: IL-10
modulates depressive-like behavior. J Psychiatr Res. 43:89–97.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ledeboer A, Brevé JJ, Wierinckx A, van der
Jagt S, Bristow AF, Leysen JE, Tilders FJ and Van Dam AM:
Expression and regulation of interleukin-10 and interleukin-10
receptor in rat astroglial and microglial cells. Eur J Neurosci.
16:1175–1185. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ledeboer A, Brevé JJ, Poole S, Tilders FJ
and Van Dam AM: Interleukin-10, interleukin-4, and transforming
growth factor-β differentially regulate lipopolysaccharide-induced
production of pro-inflammatory cytokines and nitric oxide in
co-cultures of rat astroglial and microglial cells. Glia.
30:134–142. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Streit WJ, Sammons NW, Kuhns AJ and Sparks
DL: Dystrophic microglia in the aging human brain. Glia.
45:208–212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kelley KW, O'Connor JC, Lawson MA, Dantzer
R, Rodriguez-Zas SL and McCusker RH: Aging leads to prolonged
duration of inflammation-induced depression-like behavior caused by
Bacillus Calmette-Guérin. Brain Behav Immun. 32:63–69. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Isingrini E, Desmidt T, Belzung C and
Camus V: Endothelial dysfunction: A potential therapeutic target
for geriatric depression and brain amyloid deposition in
Alzheimer's disease? Curr Opin Investig Drugs. 10:46–55.
2009.PubMed/NCBI
|
|
48
|
Rotheneichner P, Lange S, O'Sullivan A,
Marschallinger J, Zaunmair P, Geretsegger C, Aigner L and
Couillard-Despres S: Hippocampal neurogenesis and antidepressive
therapy: shocking relations. Neural Plast.
2014:7239152014.PubMed/NCBI
|
|
49
|
Koo JW and Duman RS: IL-1β is an essential
mediator of the antineurogenic and anhedonic effects of stress.
Proc Natl Acad Sci USA. 105:751–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Samuels BA, Mendez-David I, Faye C, David
SA, Pierz KA, Gardier AM, Hen R and David DJ: Serotonin 1A and
serotonin 4 receptors: Essential mediators of the neurogenic and
behavioral actions of antidepressants. Neuroscientist. 22:26–45.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ramamoorthy S, Ramamoorthy JD, Prasad PD,
Bhat GK, Mahesh VB, Leibach FH and Ganapathy V: Regulation of the
human serotonin transporter by interleukin-1 β. Biochem Biophys Res
Commun. 216:560–567. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Linthorst AC, Flachskamm C, Müller-Preuss
P, Holsboer F and Reul JM: Effect of bacterial endotoxin and
interleukin-1 beta on hippocampal serotonergic neurotransmission,
behavioral activity, and free corticosterone levels: An in vivo
microdialysis study. J Neurosci. 15:2920–2934. 1995.PubMed/NCBI
|
|
53
|
Linthorst AC, Flachskamm C, Holsboer F and
Reul JM: Local administration of recombinant human interleukin-1
beta in the rat hippocampus increases serotonergic
neurotransmission, hypothalamic-pituitary-adrenocortical axis
activity, and body temperature. Endocrinology. 135:520–532. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shintani F, Kanba S, Nakaki T, Nibuya M,
Kinoshita N, Suzuki E, Yagi G, Kato R and Asai M: Interleukin-1
beta augments release of norepinephrine, dopamine, and serotonin in
the rat anterior hypothalamus. J Neurosci. 13:3574–3581.
1993.PubMed/NCBI
|
|
55
|
Zhu CB, Blakely RD and Hewlett WA: The
proinflammatory cytokines interleukin-1beta and tumor necrosis
factor-alpha activate serotonin transporters.
Neuropsychopharmacology. 31:2121–2131. 2006.PubMed/NCBI
|
|
56
|
Sperlágh B, Vizi ES, Wirkner K and Illes
P: P2X7 receptors in the nervous system. Prog Neurobiol.
78:327–346. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Clark AK, Staniland AA, Marchand F, Kaan
TK, McMahon SB and Malcangio M: P2X7-dependent release of
interleukin-1β and nociception in the spinal cord following
lipopolysaccharide. J Neurosci. 30:573–582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Seil M, El Ouaaliti M, Foumekoye S Abdou,
Pochet S and Dehaye JP: Distinct regulation by lipopolysaccharides
of the expression of interleukin-1β by murine macrophages and
salivary glands. Innate Immun. 18:14–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Roger S, Mei ZZ, Baldwin JM, Dong L,
Bradley H, Baldwin SA, Surprenant A and Jiang LH: Single nucleotide
polymorphisms that were identified in affective mood disorders
affect ATP-activated P2X7 receptor functions. J Psychiatr Res.
44:347–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Andó R, Gölöncsér F and Sperlágh B:
Modulation of P2X7 receptor function alters depressive behavior in
rodent models of depression. Front Neurosci Conference Abstract:
IBRO International Workshop 2010. 2010.
|
|
61
|
Basso AM, Bratcher NA, Harris RR, Jarvis
MF, Decker MW and Rueter LE: Behavioral profile of P2X7 receptor
knockout mice in animal models of depression and anxiety: Relevance
for neuropsychiatric disorders. Behav Brain Res. 198:83–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lawson MA, McCusker RH and Kelley KW:
Interleukin-1 beta converting enzyme is necessary for development
of depression-like behavior following intracerebroventricular
administration of lipopolysaccharide to mice. J Neuroinflammation.
10:542013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Leutscher PDC, Lagging M, Buhl MR,
Pedersen C, Norkrans G, Langeland N, Mørch K, Färkkilä M, Hjerrild
S, Hellstrand K, et al: NORDynamIC Group: Evaluation of depression
as a risk factor for treatment failure in chronic hepatitis C.
Hepatology. 52:430–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Illman J, Corringham R, Robinson D Jr,
Davis HM, Rossi JF, Cella D and Trikha M: Are inflammatory
cytokines the common link between cancer-associated cachexia and
depression? J Support Oncol. 3:37–50. 2005.PubMed/NCBI
|
|
65
|
Xia Z, DePierre JW and Nässberger L:
Tricyclic antidepressants inhibit IL-6, IL-1 β and TNF-α release in
human blood monocytes and IL-2 and interferon-γ in T cells.
Immunopharmacology. 34:27–37. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Musselman DL, Lawson DH, Gumnick JF,
Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB and
Miller AH: Paroxetine for the prevention of depression induced by
high-dose interferon alfa. N Engl J Med. 344:961–966. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lanquillon S, Krieg JC, Bening-Abu-Shach U
and Vedder H: Cytokine production and treatment response in major
depressive disorder. Neuropsychopharmacology. 22:370–379. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Trask PC, Esper P, Riba M and Redman B:
Psychiatric side effects of interferon therapy: Prevalence,
proposed mechanisms, and future directions. J Clin Oncol.
18:2316–2326. 2000.PubMed/NCBI
|
|
69
|
Yates WR and Gleason O: Hepatitis C and
depression. Depress Anxiety. 7:188–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Scheibel RS, Valentine AD, O'Brien S and
Meyers CA: Cognitive dysfunction and depression during treatment
with interferon-alpha and chemotherapy. J Neuropsychiatry Clin
Neurosci. 16:185–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gitlin N: Hepatitis B: Diagnosis,
prevention, and treatment. Clin Chem. 43:1500–1506. 1997.PubMed/NCBI
|
|
72
|
Horsmans Y: Chronic hepatitis C,
depression and interferon. J Hepatol. 42:788–789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lotrich FE, Rabinovitz M, Gironda P and
Pollock BG: Depression following pegylated interferon-alpha:
Characteristics and vulnerability. J Psychosom Res. 63:131–135.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Koprich JB, Reske-Nielsen C, Mithal P and
Isacson O: Neuroinflammation mediated by IL-1β increases
susceptibility of dopamine neurons to degeneration in an animal
model of Parkinson's disease. J Neuroinflammation. 5:82008.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sulaiman AH, Zainal NZ, Tan KS and Tan CT:
Prevalence and associations of post-stroke depression. Neurol J
Southeast Asia. 7:71–75. 2002.
|
|
76
|
Broomfield NM, Quinn TJ, Abdul-Rahim AH,
Walters MR and Evans JJ: Depression and anxiety symptoms
post-stroke/TIA: Prevalence and associations in cross-sectional
data from a regional stroke registry. BMC Neurol. 14:1982014.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ojagbemi A, Owolabi M, Atalabi M and
Baiyewu O: Stroke lesions and post-stroke depression among
survivors in Ibadan, Nigeria. Afr J Med Med Sci. 42:245–251.
2013.PubMed/NCBI
|
|
78
|
Herrmann N, Black SE, Lawrence J, Szekely
C and Szalai JP: The Sunnybrook Stroke Study: A prospective study
of depressive symptoms and functional outcome. Stroke. 29:618–624.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Herrmann LL, Le Masurier M and Ebmeier KP:
White matter hyperintensities in late life depression: A systematic
review. J Neurol Neurosurg Psychiatry. 79:619–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Huang J, Upadhyay UM and Tamargo RJ:
Inflammation in stroke and focal cerebral ischemia. Surg Neurol.
66:232–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wiart M, Davoust N, Pialat J-B, Desestret
V, Moucharrafie S, Cho TH, Mutin M, Langlois JB, Beuf O, Honnorat
J, et al: MRI monitoring of neuroinflammation in mouse focal
ischemia. Stroke. 38:131–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Tynan RJ, Naicker S, Hinwood M, Nalivaiko
E, Buller KM, Pow DV, Day TA and Walker FR: Chronic stress alters
the density and morphology of microglia in a subset of
stress-responsive brain regions. Brain Behav Immun. 24:1058–1068.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Maes M, Yirmyia R, Noraberg J, Brene S,
Hibbeln J, Perini G, Kubera M, Bob P, Lerer B and Maj M: The
inflammatory & neurodegenerative (I&ND) hypothesis of
depression: Leads for future research and new drug developments in
depression. Metab Brain Dis. 24:27–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
